-
The available results from three ezetimibe/simvastatin trials did not provide credible evidence of any adverse effects of ezetimibe on the rate of cancer association with ezetimibe administration at the present time.
-
Colesevelam is a bile-sequestering agent approved in 2000 for the treatment of hypercholesterolemia. It has recently been shown to be effective as add-on therapy for Type 2 diabetics.
-
5-α reductase inhibitors and hip fracture in men; the effects of drug-reimbursement policy on outcomes; new guidelines for type 2 diabetes; beta-blocker-associated brady-cardia is linked to CVD events; FDA Updates.
-
Women who had low serum 25(OH) vitamin D concentrations were observed to have a higher hip fracture risk independent of other factors.
-
Topical agents, both as monotherapy and in combination, have shown efficacy in management of acne. Benzoyl peroxide (BPO) is one of the most commonly used agents, but despite excellent efficacy, the side effects of skin dryness, burning, erythema, and peeling are sometimes limiting effects of treatment.
-
The ECG shown was obtained from a 60-year-old man who was seen in the office. How would you interpret this tracing if you did not have more information? Is there cause for potential concern?
-
Although the original study by Van den Berghe et al sparked interest in the use of intensive insulin therapy in the ICU, subsequent studies have cast doubt on the efficacy and safety of this practice.
-
-
Tracking the utilization of intensive care unit (ICU) resources is important in informing clinicians of patterns of use and costs of care, especially as the proportion of patients aged 65 and older increases and ICU resources remain limited.
-
This study reports on the results of a single-hospital study of a quality improvement intervention to improve palliative care in the ICU.
